Canada Upstream Bioprocessing Market Size & Outlook
Related Markets
Canada upstream bioprocessing market highlights
- The Canada upstream bioprocessing market generated a revenue of USD 736.1 million in 2023 and is expected to reach USD 1,887.2 million by 2030.
- The Canada market is expected to grow at a CAGR of 14.9% from 2024 to 2030.
- In terms of segment, bioreactors/fermenters was the largest revenue generating product in 2023.
- Cell Culture Products is the most lucrative product segment registering the fastest growth during the forecast period.
Upstream bioprocessing market data book summary
| Market revenue in 2023 | USD 736.1 million |
| Market revenue in 2030 | USD 1,887.2 million |
| Growth rate | 14.9% (CAGR from 2024 to 2030) |
| Largest segment | Bioreactors/fermenters |
| Fastest growing segment | Cell Culture Products |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
Other key industry trends
- In terms of revenue, Canada accounted for 3.1% of the global upstream bioprocessing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. upstream bioprocessing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,887.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Upstream Bioprocessing Market Scope
Upstream Bioprocessing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Kuhner Shaker | View profile | 11-50 | Birsfelden, Basel-Landschaft, Switzerland, Europe | https://kuhner.com |
| PBS Biotech | View profile | 51-100 | Camarillo, California, United States, North America | http://www.pbsbiotech.com |
| Entegris Inc | View profile | 8000 | 129 Concord Road, Billerica, MA, United States, 01821 | https://www.entegris.com |
| Meissner | View profile | 51-100 | Camarillo, California, United States, North America | https://www.meissner.com/ |
| Repligen Corp | View profile | 1783 | 41 Seyon Street, Building 1, Suite 100, Waltham, MA, United States, 02453 | https://www.repligen.com |
| Eppendorf | View profile | 1001-5000 | Hamburg, Hamburg, Germany, Europe | https://dasgip.de |
| Corning Inc | View profile | 49800 | One Riverfront Plaza, Corning, NY, United States, 14831 | https://www.corning.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Getinge AB Class B | View profile | 11862 | Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 | https://www.getinge.com |
| Avantor Inc | View profile | 14500 | 100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, United States, 19087 | https://www.avantorsciences.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Canada upstream bioprocessing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 34.86% in 2023. Horizon Databook has segmented the Canada upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of an effective regulatory framework for authorizing the sales of biosimilars and biologics is anticipated to positively influence the use of upstream bioprocessing in the coming decade. Health Canada is involved in introducing guidelines to help biomanufacturers comply with regulations and laws governing the approval of biopharmaceutical sales in Canada.
These ongoing initiatives are anticipated to accelerate the effective use of commercially available upstream bioprocessing products. Furthermore, companies are undertaking partnership and collaboration initiatives to expand their customer base in Canada.
For instance, in July 2023, High Purity New England (HPNE), a biopharma industry player supplying & delivering custom solutions and equipment, announced its partnership with Canada Clean Room (CCR) to distribute HPNE products in Canada.
Reasons to subscribe to Canada upstream bioprocessing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada upstream bioprocessing market databook
-
Our clientele includes a mix of upstream bioprocessing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into Canada upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada upstream bioprocessing market size, by use type, 2018-2030 (US$M)
Canada Upstream Bioprocessing Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
